Digirad Corporation to Present at the 9th Annual LD Micro Main Event
Nov 18, 2016 14:00 pm UTC| Business
SUWANEE, Ga., Nov. 18, 2016 -- Digirad Corporation(NASDAQ:DRAD), the leader in delivering convenient, effective, and efficient healthcare solutions on an as needed, when needed, and where needed basis, today announced...
Ferrellgas Partners, L.P. Announces First Quarter Earnings Release Date
Nov 18, 2016 14:00 pm UTC| Business
OVERLAND PARK, Kan., Nov. 18, 2016 -- On Friday, December 9, 2016, Ferrellgas Partners, L.P. (NYSE:FGP) will report earnings for its first quarter of fiscal 2017 ended October 31, 2016. James E. Ferrell, Interim Chief...
Nov 18, 2016 14:00 pm UTC| Business
– Median overall survival improved to 13.4 from 12.9 months after extended follow-up – – 64% of patients alive after one year compared to historical rates of 25-38% – – Safety profile remains favorable; no dose-limiting...
KAR Auction Services Announces Participation in Upcoming Investor Conference
Nov 18, 2016 14:00 pm UTC| Business
CARMEL, Ind., Nov. 18, 2016 -- KAR Auction Services, Inc. (NYSE:KAR) today announced its participation in the following investor conference which will also be available via live audio webcast: Bank of America, Merrill...
HSN, Inc. to Participate in the UBS Global Media & Communications Conference
Nov 18, 2016 14:00 pm UTC| Business
ST. PETERSBURG, Fla., Nov. 18, 2016 -- Interactive multichannel retailer HSN, Inc. (NASDAQ:HSNI) announced today that the company’s Chief Executive Officer, Mindy Grossman, will participate in the UBS Global Media ...
Spring Bank Pharmaceuticals Announces Financing of $15 Million
Nov 18, 2016 13:58 pm UTC| Business
HOPKINTON, Mass., Nov. 18, 2016 -- Spring Bank Pharmaceuticals, Inc. (Nasdaq:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, cancer, and...
Motif Bio plc Announces Pricing Of $25 Million U.S. Initial Public Offering and European Placing
Nov 18, 2016 13:47 pm UTC| Business
NEW YORK, Nov. 18, 2016 -- Motif Bio plc (Motif)(NASDAQ:MTFB), a clinical stage biopharmaceutical company specializing in developing novel antibiotics, today announced the pricing of its initial public offering in the...